Filter by: patients

Sort by: Helpfulness | Most Recent

1 patient evaluation for Adalimumab taken for the purpose of 'Psoriasis' with a perceived effectiveness rating of NoneNoneNoneNoneNone

Purpose: Psoriasis (Started Jul 01, 2010)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Jul 01, 2010 40 mg/0.8 mL Weekly Led_efficacy_1Led_defaultLed_defaultLed_defaultNone NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
Date
Jul 01, 2010
Advice & Tips
Saw no results, not worth the possible side effects.
  • Icon_thumb_off 0 helpful marks

1 additional evaluation for Adalimumab is not currently shared publicly.